Citadel Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,469
Closed -$1.12M 7079
2024
Q1
$1.12M Buy
26,469
+11,393
+76% +$482K ﹤0.01% 3072
2023
Q4
$630K Sell
15,076
-7,590
-33% -$317K ﹤0.01% 3501
2023
Q3
$855K Buy
+22,666
New +$855K ﹤0.01% 3203
2022
Q4
Sell
-11,425
Closed -$343K 6885
2022
Q3
$343K Sell
11,425
-6,622
-37% -$199K ﹤0.01% 4427
2022
Q2
$653K Buy
18,047
+4,458
+33% +$161K ﹤0.01% 3873
2022
Q1
$587K Sell
13,589
-4,666
-26% -$202K ﹤0.01% 4286
2021
Q4
$915K Buy
18,255
+12,250
+204% +$614K ﹤0.01% 3938
2021
Q3
$382K Buy
+6,005
New +$382K ﹤0.01% 4806
2021
Q1
Sell
-22,378
Closed -$1.64M 6935
2020
Q4
$1.64M Sell
22,378
-27,520
-55% -$2.02M ﹤0.01% 2771
2020
Q3
$2.74M Sell
49,898
-38,761
-44% -$2.13M ﹤0.01% 1985
2020
Q2
$5.9M Sell
88,659
-104,204
-54% -$6.93M ﹤0.01% 1414
2020
Q1
$11.8M Buy
192,863
+135,018
+233% +$8.26M 0.01% 901
2019
Q4
$5.09M Sell
57,845
-15,321
-21% -$1.35M ﹤0.01% 1633
2019
Q3
$5.52M Buy
73,166
+27,733
+61% +$2.09M ﹤0.01% 1593
2019
Q2
$3.88M Buy
45,433
+3,958
+10% +$338K ﹤0.01% 1853
2019
Q1
$4.48M Sell
41,475
-40,541
-49% -$4.38M ﹤0.01% 1662
2018
Q4
$6.94M Buy
82,016
+37,088
+83% +$3.14M ﹤0.01% 1227
2018
Q3
$4.42M Buy
+44,928
New +$4.42M ﹤0.01% 1613
2018
Q2
Sell
-5,968
Closed -$589K 4676
2018
Q1
$589K Buy
+5,968
New +$589K ﹤0.01% 2811
2017
Q3
Sell
-5,617
Closed -$629K 4227
2017
Q2
$629K Buy
+5,617
New +$629K ﹤0.01% 2461
2017
Q1
Sell
-8,050
Closed -$847K 4272
2016
Q4
$847K Buy
+8,050
New +$847K ﹤0.01% 2094
2016
Q2
Sell
-4,044
Closed -$579K 4015
2016
Q1
$579K Buy
+4,044
New +$579K ﹤0.01% 2125
2015
Q2
Sell
-10,308
Closed -$1.45M 4204
2015
Q1
$1.45M Buy
+10,308
New +$1.45M ﹤0.01% 1993
2014
Q4
Sell
-5,449
Closed -$839K 4037
2014
Q3
$839K Buy
+5,449
New +$839K ﹤0.01% 2100
2014
Q2
Sell
-4,642
Closed -$515K 3798
2014
Q1
$515K Buy
+4,642
New +$515K ﹤0.01% 2302